Meteora Capital »

Horizon Therapeutics shares owned by Meteora Capital

Quarter-by-quarter ownership of Horizon Therapeutics shares owned by Meteora Capital from 13F filings

Historical chart of Meteora Capital investment in Horizon Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Horizon Therapeutics held by Meteora Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Horizon Therapeutics by Meteora Capital

Quarter filed Position value Share count Share price at filing
2023-09-30 $1.3M 11k 115.69

More positions owned by Meteora Capital

Churchill Capital Corp Vii Com Cl A (CVII)
Altc Acquisition Corp Com Cl A (ALCC)
Ares Acquisition Corporation Com Cl A
Graf Acquisition Corp Iv
Churchill Capital Corp Vi Com Cl A
Roadzen Ord Shs (RDZN)
L Catterton Asia Acquisition Class A Ord Shs
Churchill Capital Corp V Com Cl A
Zalatoris Acquisition Corp Com Cl A (TCOA)
Viveon Health Acquisition Common Stock (VHAQ)
Pyrophyte Acquisition Corp Cl A Ord Shs (PHYT)
Slam Corp Cl A Shs (SLAM)
Flame Acquisition Corp Com Cl A
Leo Hldgs Corp Ii Com Cl A
Ocean Biomedical (OCEA)

View all positions for Meteora Capital

Top funds holding Horizon Therapeutics

IFP Advisors
Beacon Capital Management
Huntington National Bank

View all funds holding Horizon Therapeutics